Breast Neoplasm - Breast Cancer (Invasive)
NCT00376597
Clinical Trial Information
Trial Number: NCT00376597 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Randomized Study to Prevent Lymphedema in Women Treated for Breast Cancer
Study ID:
CALGB-70305
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT01101438
Clinical Trial Information
Trial Number: NCT01101438 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Study ID:
MA.32
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT01242800
Clinical Trial Information
Trial Number: NCT01242800 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Study ID:
E2108
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01242800-D3 | There are three submissions for PMID 34995128. This dataset, NCT01242800-D3, contains longitudinal data on patient-reported outcomes. Dataset NCT01242800-D1 contains patient characteristics, disease status, and efficacy data at step 1. Dataset NCT01242800-D2 contains disease status, treatment, and efficacy data at step 2. |
| NCT01242800-D2 | There are three submissions for PMID 34995128. This dataset, NCT01242800-D2 contains disease status, treatment, and efficacy data at step 2. Dataset NCT01242800-D1 contains patient characteristics, disease status, and efficacy data at step 1. Dataset NCT01242800-D3 contains longitudinal data on patient-reported outcomes. |
| NCT01242800-D1 | There are three submissions for PMID 34995128. This dataset, NCT01242800-D1, contains patient characteristics, disease status, and efficacy data at step 1. Dataset NCT01242800-D2 contains disease status, treatment, and efficacy data at step 2. Dataset NCT01242800-D3 contains longitudinal data on patient-reported outcomes. |
NCT01272037
Clinical Trial Information
Trial Number: NCT01272037 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A PHASE III, RANDOMIZED CLINICAL TRIAL OF STANDARD ADJUVANT ENDOCRINE THERAPY+/- CHEMOTHERAPY IN PATIENTS WITH 1-3 POSITIVE NODES, HORMONE RECEPTOR-POSITIVE AND HER2-NEGATIVE BREAST CANCERWITH RECURRENCE SCORE (RS) OF 25 OR LESS. RXPONDER: A CLINICAL TRIAL RX FORPOSITIVE NODE, ENDOCRINE RESPONSIVE BREAST CANCER
Study ID:
S1007
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT00075764
Clinical Trial Information
Trial Number: NCT00075764 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer
Study ID:
S0226
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT02115282
Clinical Trial Information
Trial Number: NCT02115282 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
- Breast Neoplasm - Miscellaneous
Trial Title:
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Study ID:
E2112
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02115282-D2 | There are two submissions for PMID 34357781. This dataset, NCT02115282-D2, contains toxicity data. Dataset NCT02115282-D1 contains baseline, treatment, and efficacy data |
| NCT02115282-D1 | There are two submissions for PMID 34357781. This dataset, NCT02115282-D1, contains baseline, treatment, and efficacy data. Dataset NCT02115282-D2 contains toxicity data. |
NCT02445391
Clinical Trial Information
Trial Number: NCT02445391 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Study ID:
EA1131
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02445391-D3 | There are three submissions for PMID 34092112. This dataset, NCT02445391-D3, contains toxicity data. Dataset NCT02445391-D1 contains baseline, treatment, and efficacy data. Dataset NCT02445391-D2 contains data on dose modification. |
| NCT02445391-D2 | There are three submissions for PMID 34092112. This dataset, NCT02445391-D2 contains data on dose modification. Dataset NCT02445391-D1 contains baseline, treatment, and efficacy data. Dataset NCT02445391-D3 contains toxicity data. |
| NCT02445391-D1 | There are three submissions for PMID 34092112. This dataset, NCT02445391-D1, contains baseline, treatment, and efficacy data. Dataset NCT02445391-D2 contains data on dose modification. Dataset NCT02445391-D3 contains toxicity data. |
NCT00127205
Clinical Trial Information
Trial Number: NCT00127205 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
PHASE III TRIAL OF BISPHOSPHONATES AS ADJUVANT THERAPY FOR PRIMARY BREAST CANCER
Study ID:
S0307
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00127205-D2 | There are two datasets associated with PMID 31693129: NCT00127205-D1 and NCT00127205-D2. This dataset, NCT00127205-D2, will allow users to reproduce the toxicity results reported in J Natl Cancer Inst. (2020 Jul 1;112(7):698-707. doi: 10.1093/jnci/djz215. PMID: 31693129; PMCID: PMC7357327) for trial NCT00127205. |
| NCT00127205-D1 | There are two datasets associated with PMID 31693129: NCT00127205-D1 and NCT00127205-D2. This dataset, NCT00127205-D1, will allow users to reproduce the patient characteristics, treatment completion, and primary outcome results reported in J Natl Cancer Inst. (2020 Jul 1;112(7):698-707. doi: 10.1093/jnci/djz215. PMID: 31693129; PMCID: PMC7357327) for trial NCT00127205. |
NCT00382070
Clinical Trial Information
Trial Number: NCT00382070 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Study ID:
NSABP-B-42
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00382070-D2 | There are two data submissions (NCT00382070-D1 and NCT00382070-D2) for PMID 30509771, the primary publication for NCT00382070 (NSABP-B-42). This dataset, NCT00382070-D2, contains toxicity data. |
| NCT00382070-D1 | There are two data submissions (NCT00382070-D1 and NCT00382070-D2) for PMID 30509771, the primary publication for NCT00382070 (NSABP-B-42). This dataset, NCT00382070-D1, contains baseline characteristic, survival, disease recurrence, and serious adverse event data. |
NCT00433511
Clinical Trial Information
Trial Number: NCT00433511 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Study ID:
E5103
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00433511-D6 | This dataset, NCT00433511-D6, contains the analysis data published in PMID 24584876, a publication focusing on a subgroup of patients from ECOG-ACRIN trial E5103 (women who were premenopausal at enrollment, responded to the 12-month survey, had not undergone bilateral oophorectomy or ovarian function suppression before that survey, and had serum banked for research before chemotherapy). Data that are identical to those presented in NCT00433511-D1 (for the trial’s primary publication, PMID 30040523) are not duplicated here in this submission for NCT00433511-D6. |
| NCT00433511-D5 | Dataset NCT00433511-D5 contains data on time to local-regional recurrence and time to distant recurrence that were collected on the trial, but not published. NCT00433511-D1, D2, and -D4 contain data from E3805’s primary publication, PMID 30040523. Patients in the NCT00309985-D1, -D2 -D4, and -D5 data submissions have the same deidentified patient IDs. |
| NCT00433511-D4 | There are four submissions for PMID 30040523 (trial NCT00433511). This dataset, NCT00433511-D4, contains updated variables ttchf, ttbev, and os that have undergone further data cleaning from those in Dataset NCT00433511-D1 which corresponds to data used to generate the results for PMID 30040523. Dataset NCT00433511-D2 contains toxicity data. Dataset NCT00433511-D5 contains data on time to local-regional recurrence and time to distant recurrence that were collected on the trial, but not published. |
| NCT00433511-D3 | This data submission, NCT00433511-D3, contains the data used to generate the results in PubMed ID PMID: 30054636; PMCID: PMC6385891, a non-primary publication from trial NCT00433511. Data that are identical to those presented in NCT00433511-D1 (for the trial's primary publication, PMID 30040523) are not duplicated here in this submission for NCT00433511-D3. |
| NCT00433511-D2 | There are four submissions (each with one dataset) for PMID 30040523 (trial NCT00433511). This dataset, NCT00433511-D2, contains toxicity data. Dataset NCT00433511-D1 contains baseline, treatment, and efficacy data. Dataset NCT00433511-D4 contains updated time-to-event data that have undergone further data cleaning from those in NCT00433511-D1. Dataset NCT00433511-D5 contains data on time to local-regional recurrence and time to distant recurrence that were collected on the trial, but not published. |
| NCT00433511-D1 | There are four submissions for PMID 30040523 (trial NCT00433511). This dataset, NCT00433511-D1, contains baseline, treatment, and efficacy data. Dataset NCT00433511-D2 contains toxicity data. Dataset NCT00433511-D4 contains updated time-to-event data that have undergone further data cleaning from those in NCT00433511-D1. Dataset NCT00433511-D5 contains data on time to local-regional recurrence and time to distant recurrence that were collected on the trial, but not published. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®